Dario Included in Vitality's Gateway Flex Program; J&J Q3 '20 Earnings Update
Here is a brief preview of this blast: Dario announced it has been chosen for inclusion in Vitality's new Gateway Flex offering. J&J also hosted its Q3 '20 earnings call (press release; slides), and unsurprisingly, there was significant discussion surrounding the recent pause on J&J's COVID-19 vaccine trial due to an unknown illness in one of the trial participants (view statement from J&J). Below, FENIX provides insight into the impact of Gateway Flex on Dario's business as well as diabetes-related financial highlights from the J&J earnings call.